These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5688267)

  • 1. Comparison of the antilipemic effect of nicotinic acid (NA) and 3-methylpyrazole-5-carboxylic acid (MPC) in rats.
    Tamási G; Borsy J; Patthy A
    Biochem Pharmacol; 1968 Sep; 17(9):1789-94. PubMed ID: 5688267
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of 5-methylpyrazole-3-carboxylic acid (U-19425) and nicotinic acid on lipolysis in vitro and in vivo and on cyclic-3',5'-AMP phosphodiesterase.
    Kupiecki FP; Marshall NB
    J Pharmacol Exp Ther; 1968 Mar; 160(1):166-70. PubMed ID: 4295670
    [No Abstract]   [Full Text] [Related]  

  • 3. Antilipaemic effect of nicotinamide.
    Dalton C
    Nature; 1967 Nov; 216(5117):825. PubMed ID: 4229354
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of 5-methylpyrazole-3-carboxylic acid on adipose tissue. II. Antilipolytic and hypoglycemic effects in vivo.
    Froesch ER; Waldvogel M; Meyer UA; Jakob A; Labhart A
    Mol Pharmacol; 1967 Sep; 3(5):442-52. PubMed ID: 6052709
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypocholesterolemic indole-2-carboxylic acids.
    Kariya T; Grisar JM; Wiech NL; Blohm TR
    J Med Chem; 1972 Jun; 15(6):659-62. PubMed ID: 5030934
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship of nicotinamide and nicotinic acid to hypolipidemia.
    Dalton C; VanTrabert TC; Dwyer JX
    Biochem Pharmacol; 1970 Sep; 19(9):2609-19. PubMed ID: 4249087
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in serum triglyceride and cholesterol levels independently of free fatty acid after lipolysis inhibitors.
    Tamási G; Borsy J; Gyenge R
    Biochem Pharmacol; 1970 May; 19(5):1826-30. PubMed ID: 5513963
    [No Abstract]   [Full Text] [Related]  

  • 8. Stimulation of lipolysis in adipose tissue in vitro by inhibitors of lipid mobilization.
    Kupiecki FP; Schneider DI
    J Lipid Res; 1970 Jan; 11(1):38-41. PubMed ID: 5411983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of 3-carboxyl-5-methylpyrazole (CMP) on serum and liver lipids in rats.
    Tamási G; Borsy J; Patthy A
    Med Pharmacol Exp Int J Exp Med; 1967; 16(6):573-8. PubMed ID: 6072435
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of nicotinic acid on plasma lipids in patients with hyperlipoproteinemia during the first week of treatment.
    Carlson LA; Orö L; Ostman J
    J Atheroscler Res; 1968; 8(4):667-77. PubMed ID: 5679950
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of beta-pyridyl carbinol on plasma free fatty acids in the sheep.
    Nye ER; McCaw PA
    J Pharmacol Exp Ther; 1969 Jun; 167(2):374-6. PubMed ID: 5787873
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison of the effects of pyridine- and piperidine-carboxylic acids on the fatty acid content of the serum of rats treated with Triton WR-1339].
    Freyss-Beguin M; van Brussel E; Lechat P
    Therapie; 1970; 25(5):857-62. PubMed ID: 5486149
    [No Abstract]   [Full Text] [Related]  

  • 13. [A study of the calorigenic action of catecholamines].
    Opitz K; Chu H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(4):329-43. PubMed ID: 4235411
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the antilipolytic effects of nicotinic acid, methylisoxazole carboxylic acid, methylpyrazole carboxylic acid and insulin in isolated fat cells.
    Mengel K; Meyer PB; Ebert R; Schwabe U
    Pharmacology; 1972; 8(4):280-90. PubMed ID: 4348671
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis--nicotinic acid therapy. 3. Lipolytic effects of nicotinic acid and its derivatives].
    Lundholm L
    Lakartidningen; 1971 Apr; 68(15):1746-9. PubMed ID: 5577245
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experimental analysis of the interactions between heparin and a duodenal heparinoid].
    Marmo E; Lampa E; Vacca C; Rossi F; Spadaro R; Sannino A
    Arch Sci Med (Torino); 1975; 132(3):83-115. PubMed ID: 56927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The mode of action of nicotinic acid on the transport of lipids].
    Puglisi L; Solyom A; Usardi MM; Vertua R; Paoletti R
    Pathol Biol; 1967 Feb; 15(3):204-8. PubMed ID: 4860731
    [No Abstract]   [Full Text] [Related]  

  • 18. [Arteriosclerosis--nicotinic acid therapy. 11. Nicotinic acid and tissue triglycerides].
    Fröberg SO
    Lakartidningen; 1971 Apr; 68(15):1773-5. PubMed ID: 5577253
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the cholesterol-lowering mechanism of nicotinic acid and nicotinyl alcohol tartrate.
    Alton C; Kowalski C; Mallon J; Marschhaus C
    J Atheroscler Res; 1968; 8(2):265-76. PubMed ID: 5664196
    [No Abstract]   [Full Text] [Related]  

  • 20. Different responses of white and brown adipose tissue to drugs affecting lipolysis.
    Bizzi A; Codegoni AM; Lietti A; Garattini S
    Biochem Pharmacol; 1968 Dec; 17(12):2407-12. PubMed ID: 4305303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.